SLC7A11 and breast cancer: Although downregulation of SLC7A11 inhibits GSH synthesis and induces oxidative stress, it leads to the increased expression of the efflux transporter P-glycoprotein (P-gp), also called multidrug resistance protein 1, MDR1, and therefore induces a drug-resistant phenotype in breast cancer cells.